Why the study?
Does atropine sulphate block synaptic transmission in cardiac sympathetic adrenergic pathways?
Does atropine sulphate block synaptic transmission in cardiac sympathetic adrenergic pathways?
Atropine partially blocks synaptic transmission in cardiac sympathetic adrenergic pathways, indicating a muscarinic component in sympathetic ganglionic transmission.
Answers are grounded in this paper and cite their sources.
May suggest muscarinic component in sympathetic ganglia in animals; leaves open relevance to human cardiac sympathetic transmission.
Stimulation of the thoracic sympathetic nerve trunk caused a rise in arterial blood pressure and heart rate which was reduced but not abolished during the infusion of hexamethonium chloride, pentolinium tartrate, mecamylamine or tetraethylammonium chloride.2. Preganglionic stimulation no longer elicited a synchronous sC elevation in the post-ganglionic nerves. The persistent blood pressure and heart rate response was associated with an asynchronous discharge in these nerves.3. Both the persistent response and the asynchronous discharge were abolished by the intravenous injection of atropine sulphate in doses of 30 mug/kg.4. Atropine had no effect on spike amplitude or shape, conduction velocity or frequency response in either the pre- or post-ganglionic nerve trunks. Nor did it affect the rise in blood pressure and heart rate evoked by stimulation of the post-ganglionic cardiac sympathetic nerves.5. It is concluded that atropine partially blocked synaptic transmission in cardiac sympathetic adrenergic pathways.
No takes yet. Share an insight, caveat, or question.
Arthur Brown (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: